Petrić-Miše B - Search Results

1

Real-World Efficacy and Safety of Bevacizumab in the First-Line Treatment of Metastatic Cervical Cancer: A Cohort Study in the Total Population of Croatian Patients.

Čerina D, Matković V, Katić K, Belac Lovasić I, Šeparović R, Canjko I, Jakšić B, Petrić-Miše B, Bajić Ž, Boban M, Vrdoljak E. Čerina D, et al. Among authors: petric mise b. J Oncol. 2021 Aug 5;2021:2815623. doi: 10.1155/2021/2815623. eCollection 2021. J Oncol. 2021. PMID: 34394349 Free PMC article.

2

Long follow-up of patients with locally advanced cervical cancer treated with concomitant chemobrachyradiotherapy with cisplatin and ifosfamide followed by consolidation chemotherapy.

Petrić Miše B, Boraska Jelavić T, Strikic A, Hrepić D, Tomić K, Hamm W, Tomić S, Prskalo T, Vrdoljak E. Petrić Miše B, et al. Int J Gynecol Cancer. 2015 Feb;25(2):315-9. doi: 10.1097/IGC.0000000000000336. Int J Gynecol Cancer. 2015. PMID: 25486103

3

Optimisation of breast cancer patients' follow-up - potential way to improve cancer care in transitional countries.

Bošković L, Gašparić M, Petrić Miše B, Petković M, Gugić D, Ban M, Jazvić M, Dabelić N, Belac Lovasić I, Vrdoljak E. Bošković L, et al. Among authors: petric mise b. Eur J Cancer Care (Engl). 2017 Jul;26(4). doi: 10.1111/ecc.12514. Epub 2016 May 5. Eur J Cancer Care (Engl). 2017. PMID: 27145728

4

Efficacy and safety of TC dose-dense chemotherapy as first-line treatment of epithelial ovarian cancer: a single-institution retrospective cohort study.

Vrdoljak J, Boban T, Petrić Miše B, Boraska Jelavić T, Bajić Ž, Tomić S, Vrdoljak E. Vrdoljak J, et al. Among authors: petric mise b. Jpn J Clin Oncol. 2019 Apr 1;49(4):347-353. doi: 10.1093/jjco/hyz011. Jpn J Clin Oncol. 2019. PMID: 30796833

5

Early HER2-Positive Breast Cancer: Current Treatment and Novel Approaches.

Ban M, Petrić Miše B, Vrdoljak E. Ban M, et al. Among authors: petric mise b. Breast Care (Basel). 2020 Dec;15(6):560-569. doi: 10.1159/000511883. Epub 2020 Oct 28. Breast Care (Basel). 2020. PMID: 33447229 Free PMC article. Review.

6

Prognostic significance of MAPK, Topo IIα and E-cadherin immunoexpression in ovarian serous carcinomas.

Sundov D, Petric Mise B, Mrklic I, Bacic B, Vrdoljak E, Tomic S. Sundov D, et al. Among authors: petric mise b. Neoplasma. 2017;64(2):289-298. doi: 10.4149/neo_2017_217. Neoplasma. 2017. PMID: 28052682

7

MAGE-A10 Protein Expression in Advanced High Grade Serous Ovarian Cancer Is Associated with Resistance to First-Line Platinum-Based Chemotherapy.

Lisica Šikić N, Petrić Miše B, Tomić S, Spagnol G, Matak L, Juretić A, Spagnoli G. Lisica Šikić N, et al. Among authors: petric mise b. Cancers (Basel). 2023 Sep 23;15(19):4697. doi: 10.3390/cancers15194697. Cancers (Basel). 2023. PMID: 37835391 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Search Page

Filters